<p>The invention relates to solid states of pharmaceutically acceptable compounds of aliskiren, and processes for preparation thereof. The invention further provides pharmaceutical formulations comprising the amorphous or crystal line forms of pharmaceutically acceptable compounds of aliskiren and processes thereof; and a method of inhibiting renin for treating hypertension.</p>
申请公布号
WO2010091277(A8)
申请公布日期
2011.04.07
申请号
WO2010US23356
申请日期
2010.02.05
申请人
TEVA PHARMACEUTICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;FINKELSTEIN, NINA;MITTELMAN, ARIEL